CLOTBUST-hands free: Initial safety testing of a novel operator-independent ultrasound device in stroke-free volunteers

Stroke

Volumn 44, Issue 6, 2013, Pages 1641-1646

  Barlinn, Kristian ^a,b   Barreto, Andrew D ^d   Sisson, April ^a   Liebeskind, David S ^e   Schafer, Mark E ^f   Alleman, John ^g   Zhao, Limin ^a   Shen, Loren ^d   Cava, Luis F ^a   Rahbar, Mohammad H ^c   Grotta, James C ^d   Alexandrov, Andrei V ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c Center for Clinical and Translational Sciences   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Sonic Tech Inc   (United States)

^g Cerevast Therapeutics Inc   (United States)

Author keywords

CLOTBUST; Ischemic stroke; Operator independent device; Reperfusion therapy

Indexed keywords

ADULT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPERATOR INDEPENDENT ULTRASOUND DEVICE; PRIORITY JOURNAL; PULSE WAVE; RISK ASSESSMENT; ULTRASOUND SCANNER; ULTRASOUND TRANSDUCER;

CLOTBUST; ISCHEMIC STROKE; OPERATOR-INDEPENDENT DEVICE; REPERFUSION THERAPY;

ADULT; AGED; BLOOD-BRAIN BARRIER; BRAIN; EQUIPMENT SAFETY; FEMALE; HUMANS; INTRACRANIAL THROMBOSIS; MAGNETIC RESONANCE IMAGING; MALE; MECHANICAL THROMBOLYSIS; MIDDLE AGED; STROKE; THROMBOLYTIC THERAPY; ULTRASONIC THERAPY;

EID: 84880168554     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.001122     Document Type: Article

References (26)

1. Tsivgoulis G, Eggers J, Ribo M, Perren F, Saqqur M, Rubiera M, et al. Safety and effcacy of ultrasound-enhanced thrombolysis: a comprehensive review and meta-analysis of randomized and nonrandomized studies. Stroke. 2010;41:280-287.
2. Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, et al. Ultrasound enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med. 2004;351:2170-2178.
3. Molina CA, Barreto AD, Tsivgoulis G, Sierzenski P, Malkoff MD, Rubiera M, et al. Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial. Ann Neurol. 2009;66:28-38.
4. Ramaswami R, Zhou Y, Schafer M, Zutshi R, Alexandrov AV. Ultrasound energy levels in the CLOTBUST trial: a step towards optimization of clinical sonothrombolysis. Stroke.2008;39:610.
5. Demchuk AM, Christou I, Wein TH, Felberg RA, Malkoff M, Grotta JC, et al. Accuracy and criteria for localizing arterial occlusion with transcra-nial Doppler. J Neuroimaging. 2000;10:1-12.
6. Demchuk AM, Christou I, Wein TH, Felberg RA, Malkoff M, Grotta JC, et al. Specifc transcranial Doppler fow fndings related to the presence and site of arterial occlusion with transcranial Doppler. Stroke.2000;31:140-146.
7. Alexandrov AV, Sloan MA, Wong LK, Douville C, Razumovsky AY, Koroshetz WJ, et al.; American Society of Neuroimaging Practice Guidelines Committee. Practice standards for transcranial Doppler ultrasound: part I-test performance. J Neuroimaging. 2007;17:11-18.
8. Bang OY, Buck BH, Saver JL, Alger JR, Yoon SR, Starkman S, et al. Prediction of hemorrhagic transformation after recanalization therapy using T2*-permeability magnetic resonance imaging. Ann Neurol. 2007;62:170-176.
9. Bang OY, Saver JL, Alger JR, Shah SH, Buck BH, Starkman S, et al.; UCLA MRI Permeability Investigators. Patterns and predictors of blood-brain barrier permeability derangements in acute ischemic stroke. Stroke. 2009;40:454-461.
10. Barlinn K, Tsivgoulis G, Molina CA, Alexandrov DA, Schafer ME, Alleman J, et al. Exploratory analysis of estimated peak rarefaction pressure, recanalization and outcome in the Transcranial Ultrasound in Clinical SONothrombolysis (TUCSON) Trial. J Clin Ultrasound. 2012 Aug 28. doi: 10.1002/jcu.21978.
11. Alexandrov AV, Schafer MA. Operator-Independent Device for Sonothrombolysis. First International Sonothrombolysis Conference. Cerebrovasc Dis. 2008;26:1-18.
12. Daffertshofer M, Gass A, Ringleb P, Sitzer M, Sliwka U, Els T, et al. Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial. Stroke. 2005;36:1441-1446.
13. Reinhard M, Hetzel A, Krüger S, Kretzer S, Talazko J, Ziyeh S, et al. Blood-brain barrier disruption by low-frequency ultrasound. Stroke. 2006;37:1546-1548.
14. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke. 2007;38:967-973.
15. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al.; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317-1329.
16. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al.; ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375:1695-1703.
17. Lee M, Hong KS, Saver JL. Effcacy of intra-arterial fbrinolysis for acute ischemic stroke: meta-analysis of randomized controlled trials. Stroke. 2010;41:932-937.
18. Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, et al. Solitaire fow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 2012;380:1241-1249.
19. Nogueira RG, Lutsep HL, Gupta R, Jovin TG, Albers GW, Walker GA, et al.; TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet. 2012;380:1231-1240.
20. Barreto AD, Alexandrov AV. Adjunctive and alternative approaches to current reperfusion therapy. Stroke. 2012;43:591-598.
21. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
22. Alberts MJ, Latchaw RE, Selman WR, Shephard T, Hadley MN, Brass LM, et al.; Brain Attack Coalition. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke. 2005;36:1597-1616.
23. Alexandrov AV, Barlinn K. Taboos and opportunities in sonothromboly-sis for stroke. Int J Hyperthermia. 2012;28:397-404.
24. Devcic-Kuhar B, Pfaffenberger S, Gröschl M, Kollmann C, Benes E, Gottsauner-Wolf M. In vitro thrombolysis enhanced by standing and travelling ultrasound wave felds. Ultrasound Med Biol. 2002;28:1181-1187.
25. Barreto AD, Alexandrov AV, Shen L, Roper TC, Sisson A, Bursaw AW, et al. Combined lysis of thrombus in brain ischemia with transcranial ultrasound and systemic tPA-hands-free: results of a phase II safety pilot study. Stroke. 2012;43.
26. Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke (CLOTBUST-ER). The Internet Stroke Center. Available at http://www.strokecenter. org/trials/clinicalstudies/a-randomized-active-controlled-double-blinded-trial- of-the-combined-lysis-of-thrombus-with-ultrasound-and-systemic-tissue- plasminogen-activator-tpa-for-emergent-revascularization-clotbuster-in-acute- ischemic-stroke. Accessed November 02, 2012.